Gregor Bond
Impact in
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments
- Oncology top 5%
- Lymphatic System and Diseases
Papers in
-
- Renal Transplantation Outcomes and Treatments 48
- Oncology 9
- Polyomavirus and related diseases 6
- Co-authors
- Georg A. Böhmig (40 shared papers)Farsad Alexander Eskandary (25 shared papers)Heinz M. Regele (21 shared papers)Markus Wahrmann (23 shared papers)Željko Kikić (23 shared papers)Elisabeth Puchhammer‐Stöckl (13 shared papers)Irene Görzer (12 shared papers)Nicolas Kozakowski (19 shared papers)
In The Last Decade
Gregor Bond
77 papers receiving 2.8k citations
Gregor Bond's Hit Papers
Peers
Comparison fields: 5 of 78
- Transplantation 1.4k
- Oncology 474
- Hepatology 162
- Infectious Diseases 192
- Immunology 196
Countries citing papers authored by Gregor Bond
This map shows the geographic impact of Gregor Bond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Bond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Bond more than expected).
Fields of papers citing papers by Gregor Bond
This network shows the impact of papers produced by Gregor Bond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Bond. The network helps show where Gregor Bond may publish in the future.
Co-authors
The 25 scholars most cited alongside Gregor Bond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 309 | |
| 2 | A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection Hit paper breakdown → | 2017 | 237 |
| 3 | 2011 | 164 | |
| 4 | A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection Hit paper breakdown → | 2020 | 144 |
| 5 | 2018 | 105 | |
| 6 | 2018 | 103 | |
| 7 | 2021 | 101 | |
| 8 | 2020 | 99 | |
| 9 | 2014 | 96 | |
| 10 | 2016 | 93 | |
| 11 | 2020 | 87 | |
| 12 | 2022 | 60 | |
| 13 | 2009 | 59 | |
| 14 | 2016 | 57 | |
| 15 | 2016 | 56 | |
| 16 | 2019 | 54 | |
| 17 | 2011 | 52 | |
| 18 | 2019 | 51 | |
| 19 | 2023 | 48 | |
| 20 | 2007 | 45 |
About Gregor Bond
Gregor Bond is a scholar working on Transplantation, Oncology, Immunology, Hepatology and Infectious Diseases, having authored 79 papers that have together received 2.8k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (48 papers), Polyomavirus and related diseases (6 papers), Complement system in diseases (5 papers), Hepatitis C virus research (4 papers), Transplantation: Methods and Outcomes (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Cytomegalovirus and herpesvirus research (3 papers) and Organ Donation and Transplantation (3 papers). The work is most often cited by research in Transplantation (1.4k citations), Oncology (474 citations), Hepatology (162 citations), Infectious Diseases (192 citations) and Immunology (196 citations). Gregor Bond has collaborated with scholars based in Austria, Canada and France. Frequent co-authors include Georg A. Böhmig, Farsad Alexander Eskandary, Heinz M. Regele, Markus Wahrmann, Željko Kikić, Elisabeth Puchhammer‐Stöckl, Irene Görzer, Nicolas Kozakowski, Elisabeth Schwaiger and Konstantin Doberer. Their work appears in journals such as Transplantation, Transplant International, Nephrology Dialysis Transplantation, Journal of Clinical Virology and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.